Drug Buyers Get OK On $275M Sandoz Antitrust Settlement
By Matthew Santoni · February 20, 2025, 4:53 PM EST
Swiss drugmaker Sandoz and its subsidiaries will pay consumers, insurers and other "end payer plaintiffs" $275 million to settle class action claims that it conspired with other companies to fix the...
To view the full article, register now.